Advertisement
Advertisement
U.S. markets close in 4 hours 5 minutes
Advertisement
Advertisement
Advertisement
Advertisement

TME Pharma N.V. (0N6A.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
0.9950-0.1050 (-9.55%)
As of 09:15AM CEST. Market open.
Advertisement
Advertisement
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
Total Revenue
0
0
0
0
Cost of Revenue
-
-
-
1,029
Gross Profit
-
-
-
-1,029
Operating Expense
15,224
13,451
5,751
2,915
Operating Income
-15,224
-13,451
-5,751
-3,944
Net Non Operating Interest Income Expense
-2,971
-1,185
-4,637
3,088
Pretax Income
-18,019
-14,452
-10,406
-860
Tax Provision
1
1
0
1
Net Income Common Stockholders
-18,018
-14,452
-10,405
-861
Diluted NI Available to Com Stockholders
-18,018
-14,452
-10,405
-861
Basic EPS
-
-22.00
-32.00
-8.00
Diluted EPS
-
-22.00
-32.00
-8.00
Basic Average Shares
-
659.849
323.585
111.583
Diluted Average Shares
-
659.849
323.585
111.583
Total Operating Income as Reported
-15,048
-13,267
-5,769
-3,948
Total Expenses
15,224
13,451
5,751
3,944
Net Income from Continuing & Discontinued Operation
-18,018
-14,452
-10,405
-861
Normalized Income
-18,018
-14,452
-10,405
-861
Interest Income
385
319
418
3,091
Interest Expense
3,356
1,504
5,055
3
Net Interest Income
-2,971
-1,185
-4,637
3,088
EBIT
-14,663
-12,948
-5,351
-857
EBITDA
-14,601
-
-
-
Reconciled Cost of Revenue
-
-
-
1,029
Reconciled Depreciation
62
66
63
47
Net Income from Continuing Operation Net Minority Interest
-18,018
-14,452
-10,405
-861
Normalized EBITDA
-14,601
-12,882
-5,288
-810
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
Advertisement
Advertisement